Geke Hospers
Geke Hospers
Professor of medical oncology
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Preoperative chemoradiotherapy for esophageal or junctional cancer
P van Hagen, M Hulshof, JJB Van Lanschot, EW Steyerberg, ...
New England Journal of Medicine 366 (22), 2074-2084, 2012
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
J Shapiro, JJB Van Lanschot, MCCM Hulshof, P van Hagen, ...
The lancet oncology 16 (9), 1090-1098, 2015
Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor
YH Kusumanto, WA Dam, GAP Hospers, C Meijer, NH Mulder
Angiogenesis 6, 283-287, 2003
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in …
RR Bahadoer, EA Dijkstra, B van Etten, CAM Marijnen, H Putter, ...
The Lancet Oncology 22 (1), 29-42, 2021
Baseline Biomarkers for Outcome of Melanoma Patients Treated with PembrolizumabBiomarkers for Outcome of Pembrolizumab-Treated Patients
B Weide, A Martens, JC Hassel, C Berking, MA Postow, K Bisschop, ...
Clinical Cancer Research 22 (22), 5487-5496, 2016
Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research
D Bouïs, GAP Hospers, C Meijer, G Molema, NH Mulder
Angiogenesis 4 (2), 91, 2001
Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind …
YH Kusumanto, V Van Weel, NH Mulder, AJ Smit, J Van Den Dungen, ...
Human gene therapy 17 (6), 683-691, 2006
In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft
WB Nagengast, EG De Vries, GA Hospers, NH Mulder, JR De Jong, ...
Journal of Nuclear Medicine 48 (8), 1313-1319, 2007
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
S Kelderman, B Heemskerk, H Van Tinteren, RRH Van Den Brom, ...
Cancer Immunology, Immunotherapy 63, 449-458, 2014
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer–the RAPIDO trial
PJ Nilsson, B van Etten, GAP Hospers, L Påhlman, CJH van de Velde, ...
BMC cancer 13 (1), 1-9, 2013
Rectal and colon cancer: Not just a different anatomic site
K Tamas, AME Walenkamp, EGE De Vries, M Van Vugt, RG Beets-Tan, ...
Cancer treatment reviews 41 (8), 671-679, 2015
Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study
J Larkin, M Del Vecchio, PA Ascierto, I Krajsova, J Schachter, B Neyns, ...
The Lancet Oncology 15 (4), 436-444, 2014
A review on pro-and anti-angiogenic factors as targets of clinical intervention
D Bouïs, Y Kusumanto, C Meijer, NH Mulder, GAP Hospers
Pharmacological Research 53 (2), 89-103, 2006
PET imaging of oestrogen receptors in patients with breast cancer
M van Kruchten, EGE de Vries, M Brown, EFJ de Vries, ...
The Lancet Oncology 14 (11), e465-e475, 2013
Influence of the bystander effect on HSV-tk/GCV gene therapy. A review.
IJ van Dillen, NH Mulder, W Vaalburg, EFJ de Vries, GAP Hospers
Current gene therapy 2 (3), 307-322, 2002
A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier
NH Hendrikse, EGE De Vries, L Eriks-Fluks, WTA Van Der Graaf, ...
Cancer research 59 (10), 2411-2416, 1999
Characterization of a Human Small Cell Lung Carcinoma Cell Line with Acquired Resistance to cis-Diamminedichloroplatinum(II) in Vitro
GAP Hospers, NH Mulder, B De Jong, L De Ley, DRA Uges, ...
Cancer research 48 (23), 6803-6807, 1988
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line
C Meijer, NH Mulder, GAP Hospers, DRA Uges, EGE De Vries
British journal of cancer 62 (1), 72-77, 1990
PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma
M van Kruchten, AWJM Glaudemans, EFJ de Vries, RGH Beets-Tan, ...
Journal of Nuclear Medicine 53 (2), 182-190, 2012
Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast CancerER Availability during Fulvestrant Therapy
M van Kruchten, EG de Vries, AW Glaudemans, MC van Lanschot, ...
Cancer discovery 5 (1), 72-81, 2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20